![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Sareum Holdings Plc | LSE:SAR | London | Ordinary Share | GB00BMC3RJ87 | ORD GBP 0.0125 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 22.50 | 22.00 | 23.00 | 22.50 | 22.50 | 22.50 | 209,473 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -3.42M | -0.0317 | -7.10 | 24.29M |
Date | Subject | Author | Discuss |
---|---|---|---|
15/1/2025 15:02 | Share price is tanking again.. Needs sadoldtart to keep ramping this with 2am posts about the science and deals in our sector.. That always does a lot hahahahahaha.. | ![]() wolf2025 | |
15/1/2025 07:49 | Exactly Omnilash. As per my second to last post...companies can always have discussions with 3rd parties interested for various strategic reasons....especiall I feel it is a matter of not if we receive an offer but from how many. So effectively a bidding phase as I'm seeing elsewhere....where votes are required to approve....or politely suggest they sharpen their pencil. I lean towards thinking the monies raised were not just for trials (I agree with your opinion on the poker point) but also for legal costs.... That's my thoughts. All best 👌 | ![]() criticalthinker1 | |
15/1/2025 01:34 | A deal does not have to wait 6 months from this conference JPM or anytime tbh, after all, Bristol Myers Squibb's $74B acquisition of Celgene was announced the Thurs before the 2019 JPM conference. Also in '19, Lilly announced $8B acquisition of Loxo Oncology on the 1st day of conf that year, Mon. Last yr on the 1st day, Pfizer announced $1.3B deal w/Beam Therapeutics Keep eyes peeled. The extension for 1801 could have just been a poker move. And with nothing announced on the planned extended toxicology studies. With each passing day of silence, I smell a deal incoming. Good luck all | ![]() omnislash | |
14/1/2025 21:38 | Just putting it out there....has anyone any thoughts of the due diligence and negotiations that could be apparent if the submarine patent had or has been utilised by other companies? Be interesting to know what our legal firm are doing.... | ![]() criticalthinker1 | |
14/1/2025 17:27 | Some very intriguing deals being signed/offered so far at the JPM conference. I'm noting also that the chatter seems to be about novel drugs. One remarck made about JJ and Intra- Cellular (different fish but I take note of the sentiment) is a point I would like to think the board are in a similar position...the remark I think great companies, they’re bought, they’re not sold. We’re spending our time building our company," Mates told BioPharma Dive late last year. "However, we always entertain inbound offers, and that includes different kinds of partnerships, different strategic options. We look at all of them, and we’ll continue to do so." JPM is by invite only...so here is to hoping we hear something. Can't help but see companies of previous affiliation getting attention. All best Steadydanny | ![]() criticalthinker1 | |
14/1/2025 17:20 | Bless, the window licker cares about the share price What an absolute pillock | ![]() horridhenry | |
13/1/2025 16:26 | Another wonderful day of share price falls. If sareums share price success was in any way linked to the frequency of sadoldtarts posting, the share price would equal Nvidia. Wonderful news about 737 being handed back. Wonder who they will try and palm it off on now... Where's that licence deal/takeove? | ![]() wolf2025 | |
12/1/2025 18:56 | They are both well established mongs | ![]() horridhenry | |
12/1/2025 13:32 | If so, why is wolf and others fixated on this stock then. What are you doing following something you don't believe in for YEARS now. Either you are lying or you have serious issues or both. I see a stock I don't believe in, I move on. I see a stock i am interested in, I follow and read up on it. | ![]() omnislash | |
11/1/2025 23:38 | Agree wolf no chance of a license deal nobody wants an ancient tyk2 times have moved on no point running a trial in psoriasis to competitive only off target hard to treat low value indications left for any chance of commercialisation this is only heading one way short or sell | ![]() iamhappy1 | |
11/1/2025 20:35 | Paid ramper sadoldtart continues to be worth every penny he gets paid to ramp sareum to the moon.. Does he notice the share price has collapsed?! Hilarious that 737 was handed back. Everyone on here who was so jubilant on 2 Jan last year ended up looking very very stupid indeed hahaha... Nobody wants 737 and nothing will happen to it... Wonder when the next placing will be to pay the salaries and keep the lights on until 2026. Those waiting for a takeover or licence deal are delusional... | ![]() wolf2025 | |
10/1/2025 22:54 | I have a feeling that we have a few more TR1s to come. Possibly could be from the pool of the original HNWI's The silence thickens, as I said the longer this drags to announce the start, are we in talks pending a deal or takeover announcement. January will decide with 3 weeks to go. | ![]() omnislash | |
09/1/2025 16:23 | Also FWIW 2reincarnated has been called out on the lse IMM bb (1607hrs)....quite serious allegations...a 'wolf' in sheep's clothing possibly.... | ![]() criticalthinker1 | |
08/1/2025 19:54 | Hahahahahahahahaha! 737 got handed back on December 31st! All the happy clappy rampers from Jan 2nd last year who were so sure it was just the beginning! And the share price starts it's collapse again! I told you! But you didn't listen! | ![]() wolf2025 | |
08/1/2025 16:29 | Henry all I know is that certain promising drugs get highlighted. SRA737 should be up there...I recall this extract Conclusions SRA737 was well tolerated at doses that achieved preclinically relevant drug concentrations but single agent activity did not warrant further development as monotherapy. Given its mechanism of action resulting in abrogating DNA damage repair, further clinical development of SRA737 should be as combination therapy. Clinical trial registration Clinicaltrials.gov NCT02797964. So it's just a matter of time imo until the likes if CRUK get some media time. Tyk tok | ![]() criticalthinker1 | |
08/1/2025 15:54 | if "nothing" was going on then it would be a very sad situation after so many years. I suspect there is nothing going on | ![]() horridhenry | |
08/1/2025 15:43 | I'm convinced there is something in the offing amongst the Cambridge fraternity. Definitely movement. | ![]() criticalthinker1 | |
07/1/2025 20:09 | I smell a takeover offer. The longer it takes to announce it this month, I have my suspicions and hopes obviously. Personally, I reckon the delay and requests were designed to break SAR last year but when the placings succeeded and we can go forward. Nothing left to wait for. I really don't mind. In a couple more months, our value stands to increase by a few hundred million so why not. | ![]() omnislash | |
06/1/2025 20:47 | The reasoning (I fail to articulate propetly) I note Merck is because the covid debacle had some interesting comments on LSE Jan 25th 2021 and the stance Merck were taking. Treatments were where they were focusing | ![]() criticalthinker1 | |
06/1/2025 20:41 | Watch this space... RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Robert M. Davis, chairman and chief executive officer, and Dr. Dean Y. Li, executive vice president and president, Merck Research Laboratories, are scheduled to participate in a fireside chat at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, Jan. 13, 2025, at 4:30 p.m. PST / 7:30 p.m. EST. All best Steadydanny 👌 | ![]() criticalthinker1 | |
06/1/2025 20:18 | Henry by default of what was pushed by msm and what has since been revealed to be absolutely tosh you do yourself no favours. What did I say that is a conspiracy? As in not approved by those liberals who are resigning left right and center...why...becau You have an agenda..you were like a rabid dog destroying any proof that SRA737 was a dead duck...you may feel you are right with the return...but just watch what happens on the 20th January and soon after. It's been tiresome but I am rather excited. So back to your salt cod sunshine. | ![]() criticalthinker1 | |
04/1/2025 16:25 | Not a conspiracy theorist? You are a liar then. I have dozens of you r groundless posts | ![]() horridhenry | |
03/1/2025 21:02 | Addition to addendum. Just read SOG comment re HIV. Very interesting but might I offer him the oppurtunity to delve into Fauci and the 'trials' he did with the virus. There is a multitude of individuals very angry at msm for not being honest re his 'works'. Same as misreporting about TR and certain orphanages in Africa and covid. And who assisted funding it! OW!Its being reported elsewhere but I met with a journalist( who is published )back in 2008 who saw what was going on. Human guinea pigs who were HIV infected due to birth. The truth will out soon. I'm not a conspiracy theorist I just don't like being lied to. Those who know, know. Those who don't will find out. All best 👌 | ![]() criticalthinker1 | |
03/1/2025 20:29 | Addendum. As in forgot to mention, I sometimes don't mention the reasoning behind my posts, I just focus on what is the issue and the response required...rather than the what makes a market 'aware' and 'hungry'...re market value movement. There are a plethora of brokers/investment companies looking very closely at the upcoming FDA approvals given the awakening of individuals who can't dismiss what is apparent. It takes balls but our day is due. May the lady in the wings 🪽 ✨️ please step up to the stage 🙏 | ![]() criticalthinker1 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions